The Online Investor
Daily M&A
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Medical Instruments & Supplies M&A image Medical Instruments & Supplies M&A » By The Online Investor Staff, updated Thu., May. 9, 11:29 AM Recent mergers and acquisitions in the Medical Instruments & Supplies M&A category.

Slide #9. Baxter International Inc. Chatham Therapeutics

Acquirer: Baxter International Inc. (NYSE:BAX)
Acquiree: Chatham Therapeutics
Details: Baxter International Inc. (NYSE:BAX) and Chatham Therapeutics, LLC, today announced that Baxter has agreed to acquire all of Chatham's outstanding membership interests. As a result of the transaction, Baxter will acquire Chatham's developmental gene therapy programs directed toward the development and commercialization of treatments for hemophilia.

Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products, surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices. Co. manages its global operations based on four segments, consisting of the following geographic segments: North and South America, Europe, Middle East and Africa, and Asia-Pacific, and a global segment for its Hill-Rom Holdings, Inc. business.

Baxter International SEC Filing Email Alerts Service


Open the BAX Page at The Online Investor »

Company Name:  Baxter International Inc
Stock buyback:  BAX buyback
Website:  www.baxter.com
Sector:  Medical Instruments & Supplies
Number of ETFs Holding BAX:  90
Total Market Value Held by ETFs:  $3.04B
Total Market Capitalization:  $18.34B
% of Market Cap. Held by ETFs:  16.57%
 

Open the BAX Page at The Online Investor (in a new window) »

May 9, 2024    11:29 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree BAX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (2.62 out of 4)
10th percentile
(ranked lower than approx. 90% of all stocks covered)

Analysts' Target Price:
BAX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Medical Instruments & Supplies M&A - Slide 9 of 100 | www.TheOnlineInvestor.com | Copyright © 1998 - 2024, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.